JDR JDR Most Read Articles
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Appendix
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Qvarnstrom, M.
Right arrow Articles by Meurman, J.H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qvarnstrom, M.
Right arrow Articles by Meurman, J.H.
J Dent Res 87(5):480-484, 2008
© 2008 International and American Associations for Dental Research


RESEARCH REPORT
Clinical

Salivary Lysozyme and Prevalent Hypertension

M. Qvarnstrom1, S. Janket2,*, J.A. Jones2, P. Nuutinen3, A.E. Baird4, M.E. Nunn5, T.E. Van Dyke6, and J.H. Meurman7

1 Otorhinolaryngology/Oral and Maxillofacial Surgery, Kuopio University, Kuopio, Finland;
2 General Dentistry,
5 Health Policy and Health Services Research, and
6 Periodontology and Oral Biology, Boston University School of Dental Medicine, 100 East Newton Street, Rm. G-619, Boston, MA 02118, USA;
3 Cardiothoracic Surgery, Kuopio University Hospital, Kuopio, Finland;
4 National Institute of Neurologic Disorders and Stroke, NIH, Bethesda, MD, USA; and
7 University of Helsinki, Institute of Dentistry and Helsinki University Central Hospital, Helsinki, Finland

* corresponding author, skjanket{at}bu.edu

Although the etiology of essential hypertension is not clearly understood, endothelial dysfunction from chronic infection and/or impaired glucose metabolism may be involved. We hypothesized that salivary lysozyme, a marker for oral infection and hyperglycemia, might display a significant relationship with hypertension, an early stage of cardiovascular disease. Logistic regression analyses of the Kuopio Oral Health and Heart Study demonstrated that persons with higher lysozyme levels were more likely to have hypertension, after adjustment for age, gender, smoking, BMI, diabetes, the ratio of total cholesterol to HDL cholesterol, and C-reactive protein. The exposure to increasing quartiles of lysozyme was associated with adjusted Odds Ratios for the outcome, hypertension, 1.00 (referent), 1.25, 1.42, and 2.56 (linear trend p < 0.003). When we restricted the sample to the individuals without heart disease (N = 250), we observed a non-significant trend for increasing odds. Our hypothesis—"high salivary lysozyme levels are associated with the odds of hypertension"—was confirmed.

KEY WORDS: salivary lysozyme • hypertension • cytokines • advanced glycation end-products • endothelial dysfunction







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 2008 Institutional Access Guidelines